RecruitingPhase 1NCT07261631
Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
Sponsor: Novartis Pharmaceuticals
Princeton, NJ
2 recruiting breast cancer studies with a site in Princeton, NJ.
Sponsor: Novartis Pharmaceuticals
Princeton, NJ
Sponsor: Cellectar Biosciences, Inc.
Princeton, NJ · +3 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.